EODData

FRA, R5XA: ACELRX PHARMACEUT. DL-01

18 Aug 2026
LAST:

1.0000

CHANGE:
 0.04
OPEN:
1.0000
HIGH:
1.0000
ASK:
0.0000
VOLUME:
0
CHG(%):
3.85
PREV:
1.0400
LOW:
1.0000
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 Aug 261.00001.00001.00001.00000
17 Aug 261.04001.04001.04001.04000
14 Aug 261.02001.02001.02001.02000
13 Aug 261.19001.19001.19001.19000
12 Aug 261.25001.25001.25001.25000
07 Aug 261.21001.21001.21001.21000
06 Aug 261.14001.14001.14001.14000
04 Aug 261.13001.13001.13001.13000
03 Aug 261.09001.09001.09001.09000
31 Jul 261.16001.16001.16001.16000

PROFILE

Name:ACELRX PHARMACEUT. DL-01
About:Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.
Sector:Healthcare
Address:1850 Gateway Drive, San Mateo, CA, United States, 94404
Website:https://talphera.com
ISIN:US00444T2096

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:0.17 
PEG Ratio:0.00 
Price to Sales:60,203.59 
Price to Book:3.59 
Operating Margin:-14,516.00 
Return on Assets:-0.40 
Return on Equity:-1.18 
Revenue:876 
Shares:20.5M 
Market Cap:20.5M 

TECHNICAL INDICATORS

MA5:1.1010.0%
MA10:1.1212.3%
MA20:1.1212.4%
MA50:0.981.7%
MA100:0.8320.3%
MA200:0.8715.1%
RSI14:37.68 
WPR14:-100.00 
MTM14:-0.17
ROC14:-0.15 
ATR:0.05 
Week High:1.2525.0%
Week Low:1.000.0%
Month High:1.2525.0%
Month Low:1.0015.1%
Year High:1.2525.0%
Year Low:0.32209.1%

RECENT SPLITS

Date Ratio
26 Oct 20221-20